ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

LIFE aTyr Pharma Inc

1.59
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
aTyr Pharma Inc LIFE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.59 20:00:00
개장가 저가 고가 종가 전일 종가
1.59
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/04/202421:00GLOBEaTyr Pharma to Participate in April Investor Conferences
15/03/202405:00GLOBEaTyr Pharma Announces Fourth Quarter and Full Year 2023..
28/02/202422:00GLOBEaTyr Pharma to Webcast Conference Call Reporting Fourth..
21/02/202422:00GLOBEaTyr Pharma Announces Expanded Access Program (EAP) for..
07/02/202410:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202410:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/01/202422:00GLOBEaTyr Pharma to Present Posters Highlighting Importance of..
18/01/202422:00GLOBEaTyr Pharma Announces Howard University President Emeritus..
10/01/202409:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202402:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/12/202308:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202306:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:00GLOBEaTyr Pharma Presents Poster Demonstrating Preclinical..
10/11/202307:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10/11/202306:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:06EDGAR2Form 8-K - Current report
10/11/202306:00GLOBEaTyr Pharma Announces Third Quarter 2023 Results and..
01/11/202321:00GLOBEaTyr Pharma to Present at November Investor Conferences
31/10/202321:00GLOBEaTyr Pharma Announces Dosing of First Patient in Phase 2..
26/09/202322:01EDGAR2Form 8-K - Current report
11/09/202321:04EDGAR2Form 8-K - Current report
11/09/202321:00GLOBEaTyr Pharma Presents Efzofitimod Data Demonstrating..
24/08/202321:00GLOBEaTyr Pharma to Present at the H.C. Wainwright 25th Annual..
11/08/202305:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/08/202305:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:10EDGAR2Form 8-K - Current report
10/08/202305:00GLOBEaTyr Pharma Announces Second Quarter 2023 Results and..
02/08/202305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/06/202321:00GLOBEEuropean Commission Grants Orphan Drug Designation for aTyr..
20/06/202321:00GLOBEaTyr Pharma to Present on Lead Therapeutic Candidate..
10/06/202305:00GLOBEaTyr Pharma Announces Inducement Grants Under Nasdaq Listing..
06/06/202321:00GLOBEaTyr Pharma to Highlight Advancements in tRNA Synthetase..
25/05/202321:00GLOBEaTyr Pharma to Present at the 2023 Jefferies Healthcare..
22/05/202321:00GLOBEaTyr Pharma Presents New Data on Efzofitimod Mechanism of..
12/05/202305:00GLOBEaTyr Pharma to Present at the 2023 RBC Capital Markets..
10/05/202305:00GLOBEaTyr Pharma Announces First Quarter 2023 Results and..

최근 히스토리

Delayed Upgrade Clock